ICON Acquires Phase I Unit in Texas
Dublin, Ireland-based ICON made its move into the U.S. phase I market with its acquisition of Healthcare Discoveries, a San Antonio, Texas-based 40,000-square-foot, 85-bed clinical pharmacology unit. The company, owned by Catalyst Pharma Group, was purchased by ICON for $12 million in cash and performance payments of up to $10 million to be paid by the end of 2008. The buy will more than double ICON’s total phase I capability and expand its services across the Atlantic. ICON already operates an 80-bed, full-service pharmacology unit in Manchester, England.
Chiltern Buys Second Phase I Unit in UK
London-based contract research organization (CRO) Chiltern acquired Drug Development Solutions (DDS), a phase I facility based in Dundee, Scotland. The 45-bed unit is located at the Hospital and Medical School. Including the company’s facility in Slough, Chiltern now has a total of 72 beds in its phase I division.
Other breaking news...
Company Profile: An interview with Vijai Kumar, M.D., president and chief medical officer, Excel Life Sciences
To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information.